IDTechEx Research forecasts the market for tissue engineered products to exceed $4.8 billion by the year 2028 in a new report on the topic.
New IDTechEx research focuses on tissue engineering
Tissue engineering, referring to the technologies that use physical, chemical, biological and engineering processes to control and direct the aggregate behaviour of cells, has become a field of increasing commercial interest.
Though tissue engineering as a field has been around since the late 1970s, there have been few commercial successes. However, human understanding of biology, and our ability to manipulate it, has finally reached a point where complex living tissue equivalents are being developed. The IDTechEx Research report Tissue Engineering 2018-2028: Technologies, Markets, Forecasts investigates this next generation of tissue engineering products and their potential in the next 10 years.
This report covers living tissue equivalents which contain both living cells and a 3D structure.
The biggest applications for engineered tissues are in research and development, and in medicine. This report discusses the following key applications of tissue engineering:
- Testing of cosmetics and other consumer goods
- Drug screening
- Personalized medicine
- Regenerative medicine
- Cell-based biosensors
- Food and other animal products
A chapter of Tissue Engineering 2018-2028: Technologies, Markets, Forecasts is dedicated to the use of tissue engineering products in medicine. The following classes of tissue engineered therapies are highlighted:
- Tissue engineered therapies with FDA marketing approval
- Tissue engineered therapies close to IND submission
- Competitive landscape of tissue engineered skin
- Competitive landscape of tissue engineered cartilage
Additionally, a summary of ongoing clinical trials of tissue engineered products is provided, organized by trial phase, tissue type, and sponsor.
The rest of this chapter describes and discusses the dynamics of US and EU markets, with a look at relevant regulatory pathways, exemptions, and loopholes for tissue engineered products, as well as speculations on the future of regulating this novel class of therapy.
A market forecast for tissue engineered products is provided for the years 2018 - 2028, where the total value for tissue engineered products is predicted to surpass $4.8 billion. This market is broken down into key applications of therapies (clinical use) and tissue models (research use). Key players in both applications are presented, and the value chain and relevant business models are discussed.
Separately, a forecast for 3D bioprinters, an up-and-coming technology for tissue engineering, is also provided for the years 2018 - 2028.
A wide range of approaches are still being explored in tissue engineering, and this report covers both the most innovative and cutting-edge techniques as well as more established technologies. Technologies presented in Tissue Engineering 2018-2028: Technologies, Markets, Forecasts are:
- Semi-permeable membranes
- Cell-laden hydrogels
- 3D bioprinting
- 3D printing (including thermoplastic extrusion, material jetting, stereolithography, selective laser sintering)
- Decelluarization and recellularization of organs
- Phase separation, freeze-drying, solvent casting and particle leaching, gas foaming
- Electrospinning and melt electrospinning
- Self-assembly and self-organizatio
IDTechEx works at the forefront of technology innovation; assessing new technologies and their application by providing market research and intelligence services to our clients. Our clients use our insights to help make strategic business decisions and grow their organisations. We have provided these services since 1999 to clients around the world.